Delivery Order SPE2DB20D3101-SPE2DB24FRAU2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,697.75 firm-fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award, valued at $1,165.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $1,815.44, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of QULIPTA 30 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of January 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $4,252.63 and a performance period ending on May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.79 delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 29, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite...
- This federal contract award, valued at $3,607.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.82 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
- This federal contract award, valued at $1,618.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product, with a completion date of January 21, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of QULIPTA 30 MG TABLET 30S, a prescription medication, with a ceiling value of $1,488.28. The contract has an ultimate completion date of May 17, 2024 and was awarded on April 26, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,963.27 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 16, 2022 and was awarded on March 15, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRAU2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.21 delivery order contract is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The contract has a performance period through February 27, 2024 and is priced on a firm fixed price basis. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/5/24 |